Brian Lenz insider trades: Adma Biologics (ADMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | ADMA | ↓ Sell | 389,762 | $4.53 | $1.8M | Direct | Aug 17, 2023 (1d) |
| Dec 9, 2022 | ADMA | ↑ Buy | 6,993 | $2.86 | $20K | Direct | Dec 9, 2022 (0d) |
| Oct 25, 2021 | ADMA | ↑ Buy | 30,000 | $1.00 | $30K | Direct | Oct 26, 2021 (1d) |
| Aug 11, 2020 | ADMA | ↑ Buy | 4,000 | $2.96 | $12K | Direct | Aug 12, 2020 (1d) |
| Feb 11, 2020 | ADMA | ↑ Buy | 7,142 | $3.50 | $25K | Direct | Feb 11, 2020 (0d) |
| May 17, 2019 | ADMA | ↑ Buy | 5,000 | $4.00 | $20K | Direct | May 21, 2019 (4d) |
| Jun 8, 2018 | ADMA | ↑ Buy | 5,000 | $4.78 | $24K | Direct | Jun 11, 2018 (3d) |
| Nov 9, 2017 | ADMA | ↑ Buy | 6,500 | $2.15 | $14K | Direct | Nov 13, 2017 (4d) |
| May 3, 2016 | ADMA | ↑ Buy | 2,500 | $6.50 | $16K | Direct | May 5, 2016 (2d) |
| Dec 2, 2015 | ADMA | ↑ Buy | 1,000 | $9.15 | $9K | Direct | Dec 3, 2015 (1d) |
| Mar 19, 2015 | ADMA | ↑ Buy | 750 | $8.95 | $7K | Direct | Mar 23, 2015 (4d) |
| Mar 16, 2015 | ADMA | ↑ Buy | 1,250 | $7.97 | $10K | Direct | Mar 18, 2015 (2d) |
| Aug 13, 2014 | ADMA | ↑ Buy | 500 | $9.80 | $5K | Direct | Aug 15, 2014 (2d) |
| May 22, 2014 | ADMA | ↑ Buy | 500 | $8.06 | $4K | Direct | May 27, 2014 (5d) |
| May 14, 2014 | ADMA | ↑ Buy | 1,000 | $7.50 | $8K | Direct | May 16, 2014 (2d) |
| Oct 22, 2013 | ADMA | ↑ Buy | 1,000 | $8.50 | $9K | Direct | Oct 23, 2013 (1d) |
| Dec 14, 2011 | CRMD | ↑ Buy | 14,000 | $0.34 | $5K | Direct | Dec 14, 2011 (0d) |
| Aug 16, 2010 | CRMD | ↑ Buy | 1,000 | $1.54 | $2K | Direct | Aug 18, 2010 (2d) |
| Jan 14, 2008 | VQPH | ↑ Buy | 10,000 | $0.12 | $1K | Direct | Jan 14, 2008 (0d) |
| Dec 9, 2005 | VQPH | ↑ Buy | 5,000 | $0.80 | $4K | Direct | Dec 9, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADMA insiders
Open-market trades in the last 12 months
About Brian Lenz's insider trades
Brian Lenz is EVP, CFO at Adma Biologics (ADMA). Since Dec 9, 2005, Brian has reported 19 open-market purchases worth $223K and 1 sale worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), shares withheld for taxes (13 filings), other transactions (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.